Pillstats
OTC · Tablet, Film Coated, Extended Release · Oral

Loratadine And Pseudoephedrine Sulfate

Brands: Alavert Allergy And Congestion D-12 Hour · Leader Allergy Relief D-24 · Loratadine + Pseudoephedrine Sulfate

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)28889
US makers10 labelers
Packages21
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.168$0.336$0.505$0.673Dec 2025Apr 2026Jul 2026
$0.580
Latest avg · Jul 22, 2026
+4%
Since Dec 17, 2025
10
Active US suppliers
29%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.4K13K19K26K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.9K
Rx · 2026 Q1
276K
Units dispensed
-47%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Strategic Sourcing Services LLCunknown4SUPPLYING
Foundation Consumer Brandsunknown2SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING
Safewayunknown2SUPPLYING
THE KROGER CO.unknown2SUPPLYING
HEBunknown2SUPPLYING
PUBLIX SUPER MARKETS, INCunknown2SUPPLYING
Cardinal Healthunknown2SUPPLYING
Meijer Distribution, Incunknown2SUPPLYING
Amerisource Bergenunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 12, 2021
    RECALLRecall (Class III): Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg…

    Failed Moisture Limits — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide within the United States

  • Feb 7, 2014
    RECALLRecall (Class II): Non-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg , Loratadine, USP…

    Defective Container: An unacceptable level of blister defects have been identified in Loratadine and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg. — Recalling firm: Ohm Laboratories, Inc. — CA OH, PA, RI,& TX